ATE503846T1 - Verfahren zur diagnose eines ovarialkarzinoms - Google Patents

Verfahren zur diagnose eines ovarialkarzinoms

Info

Publication number
ATE503846T1
ATE503846T1 AT06790705T AT06790705T ATE503846T1 AT E503846 T1 ATE503846 T1 AT E503846T1 AT 06790705 T AT06790705 T AT 06790705T AT 06790705 T AT06790705 T AT 06790705T AT E503846 T1 ATE503846 T1 AT E503846T1
Authority
AT
Austria
Prior art keywords
subject
diagnosis
sample
markers
ovarial carcinoma
Prior art date
Application number
AT06790705T
Other languages
English (en)
Inventor
Page Cecile Le
Anne-Marie Mes-Masson
Diane Provencher
Patricia Tonin
Thomas Hudson
Original Assignee
Val Chum S E C
Univ Mcgill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Val Chum S E C, Univ Mcgill filed Critical Val Chum S E C
Application granted granted Critical
Publication of ATE503846T1 publication Critical patent/ATE503846T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT06790705T 2005-09-15 2006-09-15 Verfahren zur diagnose eines ovarialkarzinoms ATE503846T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71694105P 2005-09-15 2005-09-15
PCT/CA2006/001536 WO2007030949A2 (en) 2005-09-15 2006-09-15 Methods of diagnosing ovarian cancer and kits therefor

Publications (1)

Publication Number Publication Date
ATE503846T1 true ATE503846T1 (de) 2011-04-15

Family

ID=37865291

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06790705T ATE503846T1 (de) 2005-09-15 2006-09-15 Verfahren zur diagnose eines ovarialkarzinoms

Country Status (7)

Country Link
US (1) US7910318B2 (de)
EP (1) EP1924710B1 (de)
AT (1) ATE503846T1 (de)
CA (1) CA2622332A1 (de)
DE (1) DE602006021038D1 (de)
ES (1) ES2363757T3 (de)
WO (1) WO2007030949A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
EP2589668A1 (de) 2006-06-14 2013-05-08 Verinata Health, Inc Analyse seltener Zellen mittels Probentrennung und DNA-Etiketten
EP2029779A4 (de) 2006-06-14 2010-01-20 Living Microsystems Inc Verwendung hoch paralleler snp-genotypisierung zur fötalen diagnose
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
JP2010532484A (ja) 2007-06-29 2010-10-07 コレロジック システムズ，インコーポレイテッド 卵巣癌のための予測マーカー
US20090088400A1 (en) * 2007-09-11 2009-04-02 Puymirat Jack Prostaglandin e2 modulation and uses thereof
RU2010147643A (ru) * 2008-04-23 2012-05-27 Хелтлинкс Лимитед (Au) Анализ для детекции гинекологического состояния
US20100112575A1 (en) 2008-09-20 2010-05-06 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive Diagnosis of Fetal Aneuploidy by Sequencing
TWI427292B (zh) * 2008-11-07 2014-02-21 Tung S Taichung Metrohabor Hospital 檢測轉移性癌症之方法及套組
US20110201008A1 (en) * 2009-12-01 2011-08-18 University Of Miami Assays, methods and kits for measuring response to therapy and predicting clinical outcome in patients with b-cell lymphoma
RU2600891C2 (ru) * 2010-08-26 2016-10-27 Юниверсити Оф Вашингтон Тру Итс Сентер Фор Коммерсиализейшен Способы выявления антител против не4 и способы диагностики и/или прогнозирования состояний, ассоциированных с экспрессирующими не4 клетками
PT3041864T (pt) 2013-09-05 2021-10-26 Ab2 Bio Sa Proteína de ligação a il-18 (il-18bp) em doenças inflamatórias
JP7274259B2 (ja) 2015-03-05 2023-05-16 エイビー２ バイオ ソシエテアノニム 炎症性疾患におけるｉｌ－１８結合タンパク質（ｉｌ－１８ｂｐ）および抗体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040010121A1 (en) * 2001-03-16 2004-01-15 Birse Charles E. 7 Human ovarian and ovarian cancer associated proteins
US7189507B2 (en) * 2001-06-18 2007-03-13 Pdl Biopharma, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
AU2003235749A1 (en) 2002-01-07 2003-07-24 John Hopkins University Biomarkers for detecting ovarian cancer
EP1540010B8 (de) * 2002-08-06 2010-07-14 The Johns Hopkins University Verwendung von biomarkern zum nachweis von eierstockkrebs
JP2007502983A (ja) * 2003-08-15 2007-02-15 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション がん検出のための多因子アッセイ
EP2336779B1 (de) 2004-02-19 2013-07-31 Yale University Kit für die Identifizierung von Ovarial-Krebsprotein-Biomarkern unter Verwendung von Proteomtechniken

Also Published As

Publication number Publication date
EP1924710A4 (de) 2008-10-29
WO2007030949A2 (en) 2007-03-22
WO2007030949A3 (en) 2007-05-03
CA2622332A1 (en) 2007-03-22
US20080248501A1 (en) 2008-10-09
US7910318B2 (en) 2011-03-22
EP1924710A2 (de) 2008-05-28
EP1924710B1 (de) 2011-03-30
DE602006021038D1 (de) 2011-05-12
ES2363757T3 (es) 2011-08-16

Similar Documents

Publication Publication Date Title
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
NZ701807A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
WO2008021290A9 (en) Organ-specific proteins and methods of their use
ATE408828T1 (de) Verfahren zur erkennung eines ovarialkarzinoms
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
WO2007114986A3 (en) Cooperative probes and methods of using them
DE602007007775D1 (de) Reagenz für hämoglobinabbau
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
TW200745551A (en) Device and methods for detecting and quantifying one or more target agents
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins
MX2007007194A (es) Metodo de diagnostico de enfermedades hepaticas.
ATE472611T1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
ATE509270T1 (de) Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung
DE602005014659D1 (de) Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs
ATE353544T1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
ATE531822T1 (de) Diagnose von prostatakrebs
DE602006017228D1 (de) Verfahren zur diagnose von tumoren durch messung des niveaus von apolipoprotein a-iv
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs
ATE508366T1 (de) Polypeptidmarker zur diagnose von arteriosklerose
ATE410691T1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties